First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous Warts

Cutaneous Warts Clinical Trial

Official title:
A Phase I/IIa Open-label First-in-Human Study to Assess Safety and Pharmacokinetics and Explore Biomarker Effects of Topical Ionic Contra-viral Therapy (ICVT) Comprised of CLS003 in Subjects With Cutaneous Warts

Status Completed

Clinical Trial Summary

This phase I/IIa study has an open-label, First-in-Human (FIH), single center design to assess the safety, pharmacokinetics (PK) and pharmacodynamics (PD) of multiple doses of topically applied CLS003 in healthy subjects with cutaneous warts.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02106260
Study type	Interventional
Source	Cutanea Life Sciences, Inc.
Contact
Status	Completed
Phase	Phase 1/Phase 2
Start date	March 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05739786` - Comparisom of Liquid Nitrogen and Vitamin D3 in The Treatment of Cutaneous Warts	Phase 1
Recruiting	`NCT00644579` - bLAC - Treatment of Cutaneous Warts in Immune Suppressed, Kidney Transplanted Patients	Phase 2
Completed	`NCT03846648` - CyPep-1 in Cutaneous Warts	Phase 1
Not yet recruiting	`NCT05902624` - Efficacy and Safety of Hepatitis B Virus Vaccine(HBV) in Treatment of Cutaneous Warts	Early Phase 1
Completed	`NCT02333643` - A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts.	Phase 2
Completed	`NCT05023408` - Intralesional Bleomycin Versus Cryotherapy for Treatment of Cutaneous Warts	Phase 2
Completed	`NCT05862441` - A Study to Assess the Efficacy of Omnivirol-Salicylic Acid Combination Therapy for Cutaneous Warts With Emphasis on Persistent Warts	Phase 2/Phase 3
Completed	`NCT03734003` - Infrared Bioeffect System for the Treatment of Cutaneous Warts	N/A